DavidCharlesHalversonMD

Oncology • Canton, MI

Senior Clinical Staff at Experimental Transplantation and Immunology Branch

Join to view full profile

Dr. Halverson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Halverson's full profile

Already have an account?

Office
1150 Heatherlea Ct
Canton, MI 48188
Phone+1 734-999-3090

Fax+1 518-240-4431

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1993 - 1997
Wellstar Health System/Wellstar Cobb HospitalResidency, Internal Medicine, 1991 - 1993
WellStar Atlanta Medical CenterInternship, Transitional Year, 1990 - 1991
Medical College of Georgia at Augusta UniversityClass of 1990

Certifications & Licensure

MI State Medical License 2017 - 2025
MD State Medical License 2007 - 2018
GA State Medical License 1992 - 2009
VA State Medical License 1998 - 2006
AL State Medical License 1997 - 2002
WV State Medical License 1993 - 1996
PA State Medical License 1991 - 1992
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

140 citations
Molecular profiling of patients with pancreatic cancer: Initial results from the know your tumor initiative
Michael J. Pishvaian, Robert J. Bender, David Halverson, Lola Rahib, Andrew Eugene Hendifar
Clinical Cancer Research. 2018-10-15
14 citations
Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease.
Filip Pirsl, Lauren M. Curtis, Seth M. Steinberg, Sri Harsha Tella, Mašenjka Katić
Biology of Blood and Marrow Transplantation. 2016-08-01
8 citations
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses.
Miriam E. Mossoba, David Halverson, Roger Kurlander, Bazetta Blacklock Schuver, Ashley Carpenter
Clinical Cancer Research. 2015-06-12

Press Mentions

Perthera, Inc. Builds Its Senior Management TeamApril 6th, 2017